Cipher Mining Announces August 2024 Operational Update
September 03, 2024 18:05 ET
|
Cipher Mining Inc.
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for August 2024. Key...
Algoma Steel Group to Participate in the Jefferies 2024 Industrials Conference
September 03, 2024 17:30 ET
|
Algoma Steel Inc
SAULT STE. MARIE, Ontario, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel...
Hooker Furnishings Declares Quarterly Dividend
September 03, 2024 17:25 ET
|
Hooker Furnishings Corporation
MARTINSVILLE, Va., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) announced that on September 3, 2024, its board of directors declared a quarterly cash dividend...
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 03, 2024 17:14 ET
|
Royalty Pharma plc
NEW YORK and COPENHAGEN, Denmark, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Ascendis Pharma A/S (Nasdaq: ASND) today announced that Royalty Pharma and Ascendis Pharma...
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
September 03, 2024 17:06 ET
|
Ascendis Pharma
COPENHAGEN, Denmark and NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Ascendis Pharma Bone Diseases A/S,...
Ascendis Pharma Reports Second Quarter 2024 Financial Results
September 03, 2024 17:04 ET
|
Ascendis Pharma
YORVIPATH approved by U.S. Food & Drug Administration (FDA) as the first and only treatment of hypoparathyroidism in adultsTransCon CNP (navepegritide) pivotal ApproaCH Trial topline results...
Iovance Biotherapeutics to Present at Upcoming Conferences
September 03, 2024 17:00 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
September 03, 2024 16:50 ET
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 03, 2024 16:40 ET
|
ZENTALIS PHARMACEUTICALS
SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small...
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024
September 03, 2024 16:35 ET
|
Vision Sensing Acquisition Corp.
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024